IDX Integral Diagnostics Ltd
- 2.910
- +0.010+0.34%
Integral Diagnostics Ltd News
Positive Report for Integral Diagnostics Ltd. (IDX) From Jarden
Integral Diagnostics Ltd: AGM - CEO Address and Presentation
Capital Health's Merger With Integral Diagnostics to Head to Court on Nov. 1
The Past Three Years for Integral Diagnostics (ASX:IDX) Investors Has Not Been Profitable
Integral Diagnostics Upgraded to Buy From Overweight by Jarden
Integral Diagnostics Limited's (ASX:IDX) Market Cap Touched AU$695m Last Week, Benefiting Both Retail Investors Who Own 42% as Well as Institutions
Integral Diagnostics Price Target Raised 10% to A$3.30/Share by Ord Minnett
Ord Minnett Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Australian Healthcare Players See Wage Indexation Benefits, Margin Expansion in Fiscal 2025, Jarden Research Says
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
Wall Street Analysts Are Bullish on Top Healthcare Picks
Competition Watchdog to Invite Comments on Proposed Capitol Health-Integral Diagnostics Merger
Positive Report for Integral Diagnostics Ltd. (IDX) From Wilsons
Ord Minnett Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Raised to Overweight From Mkt Weight by Wilsons >IDX.AU
Integral Diagnostics Price Target Raised 11% to A$3.00/Share by Ord Minnett
Integral Diagnostics Ltd To Go Ex-Dividend On August 30th, 2024 With 0.033 AUD Dividend Per Share
Two Up, One Down: ASX Healthcare Stocks Split After FY24 Results
Integral Diagnostics Ltd: FY24 Investor Presentation
Analysis
Price Target
No Data
No Data